SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Leerink's biotech analyst holds an analyst/industry conference call

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
krunchtimepicks Member Profile
 
Followed By 9
Posts 1,475
Boards Moderated 0
Alias Born 03/05/06
160x600 placeholder
Biotech Stocks Forge Ahead With Confidence on This Week's Healthy Biotech Rally "PR Newswire (US)" - 11/17/2016 8:45:00 AM
Amarin to Present at the Jefferies 2016 London Healthcare Conference "GlobeNewswire Inc." - 11/11/2016 10:27:10 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/10/2016 5:02:06 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/3/2016 6:14:38 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/3/2016 6:11:40 AM
Amarin Reports Third Quarter 2016 Financial Results and Provides Update on Operations "GlobeNewswire Inc." - 11/3/2016 5:30:00 AM
Amarin to Report Third Quarter 2016 Results and Host Conference Call on November 3, 2016 "GlobeNewswire Inc." - 10/27/2016 4:56:08 PM
Pure EPA Vascepa® Now Available in New, Smaller Half-Gram Capsule Size "GlobeNewswire Inc." - 10/25/2016 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/23/2016 4:46:18 PM
KinerjaPay Corp. (OTC QB: KPAY) Announces Partnership with 62hall – Forecasts 66% Growth by Q2 2017 "InvestorsHub NewsWire" - 9/16/2016 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/14/2016 4:16:47 PM
Amarin’s REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Mo... "GlobeNewswire Inc." - 9/12/2016 5:00:00 AM
Amarin to Present at the Rodman & Renshaw 18th Annual Global Investment Conference "GlobeNewswire Inc." - 9/7/2016 7:30:00 AM
Amarin Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa "GlobeNewswire Inc." - 8/31/2016 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/26/2016 4:37:48 PM
Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in May 2014 and November 2015 "GlobeNewswire Inc." - 8/26/2016 4:20:12 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/15/2016 7:38:34 AM
Amarin Announces Underwriters’ Exercise of Option to Purchase Additional American Depositary Shares "GlobeNewswire Inc." - 8/15/2016 7:30:00 AM
Securities Registration (ads, Immediate) (f-6ef) "Edgar (US Regulatory)" - 8/12/2016 4:42:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/12/2016 4:12:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/12/2016 4:07:45 PM
Amarin Prices Public Offering of American Depositary Shares "GlobeNewswire Inc." - 8/11/2016 9:20:13 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 8/10/2016 5:20:14 PM
Amarin Announces Proposed Public Offering of American Depositary Shares "GlobeNewswire Inc." - 8/10/2016 4:10:47 PM
Entertainment & Action Oriented Event Stocks Offer More Sophisticated Thrills For Consumers Leading to Multi-Million Dollar "InvestorsHub NewsWire" - 8/4/2016 9:15:00 AM
krunchtimepicks   Wednesday, 03/09/11 04:25:47 PM
Re: None
Post # of 96765 
Leerink's biotech analyst holds an analyst/industry conference call
Biotech Analyst Schwartz discusses prospects for Amarin's AMR-101 in the treatment of mixed Dyslipidemia: previewing the ANCHOR Study on an Analyst/Industry conference call being held on March 10 at 11 am hosted by Leerink.

www.theflyonthewall.com/.../AMRNid1391681/AMRN-Leerinks-biotech-analyst-holds-an-analystindustry-conference-call

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist